Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:JNJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$193.27+0.6%$180.49$140.68▼$194.40$465.34B0.49.68 million shs7.73 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson0.00%+1.37%+10.91%+18.10%+17.64%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$193.27+0.6%$180.49$140.68▼$194.40$465.34B0.49.68 million shs7.73 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson0.00%+1.37%+10.91%+18.10%+17.64%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJNJJohnson & Johnson 2.74Moderate Buy$199.883.42% UpsideCurrent Analyst Ratings BreakdownLatest JNJ Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/16/2025JNJJohnson & JohnsonHSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$210.00 ➝ $215.0010/15/2025JNJJohnson & JohnsonArgusSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$210.0010/15/2025JNJJohnson & JohnsonRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$174.00 ➝ $209.0010/15/2025JNJJohnson & JohnsonMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$190.0010/15/2025JNJJohnson & JohnsonStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$165.00 ➝ $190.0010/15/2025JNJJohnson & JohnsonCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$213.00 ➝ $215.0010/15/2025JNJJohnson & JohnsonBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$198.00 ➝ $204.0010/14/2025JNJJohnson & JohnsonCowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy10/14/2025JNJJohnson & JohnsonUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$190.00 ➝ $214.0010/10/2025JNJJohnson & JohnsonRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$209.00(Data available from 10/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJNJJohnson & Johnson$88.82B5.24$13.12 per share14.73$29.69 per share6.51Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJNJJohnson & Johnson$14.07B$10.3618.6517.462.2727.26%33.08%13.30%N/ALatest JNJ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/14/2025Q3 2025JNJJohnson & Johnson$2.76$2.80+$0.04$2.12$23.73 billion$23.99 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthJNJJohnson & Johnson$5.202.69%N/A50.19%64 YearsLatest JNJ DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date10/14/2025JNJJohnson & Johnsonquarterly$1.302.72%11/25/202511/25/202512/9/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJNJJohnson & Johnson0.501.010.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJNJJohnson & Johnson69.55%Insider OwnershipCompanyInsider OwnershipJNJJohnson & Johnson0.16%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJNJJohnson & Johnson138,1002.41 billion2.40 billionOptionableJNJ HeadlinesRecent News About These CompaniesSubcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer5 hours ago | prnewswire.comJohnson & Johnson (NYSE:JNJ) Given New $215.00 Price Target at HSBCOctober 19 at 9:44 AM | marketbeat.comChevy Chase Trust Holdings LLC Buys 9,043 Shares of Johnson & Johnson $JNJOctober 19 at 4:49 AM | marketbeat.comTweedy Browne Co LLC Has $37.38 Million Stock Position in Johnson & Johnson $JNJOctober 19 at 4:49 AM | marketbeat.comJohnson & Johnson $JNJ Shares Sold by Easterly Investment Partners LLCOctober 19 at 4:49 AM | marketbeat.comArista Wealth Management LLC Takes $1.49 Million Position in Johnson & Johnson $JNJOctober 19 at 4:49 AM | marketbeat.comStratos Wealth Partners LTD. Trims Stake in Johnson & Johnson $JNJOctober 19 at 4:49 AM | marketbeat.comAssuredPartners Investment Advisors LLC Has $957,000 Stake in Johnson & Johnson $JNJOctober 19 at 4:49 AM | marketbeat.comPrivate Trust Co. NA Has $6.20 Million Stock Holdings in Johnson & Johnson $JNJOctober 19 at 4:39 AM | marketbeat.comAngeles Wealth Management LLC Has $2.30 Million Stock Holdings in Johnson & Johnson $JNJOctober 19 at 4:39 AM | marketbeat.comJohnson & Johnson $JNJ Stock Position Lessened by Applied Finance Capital Management LLCOctober 19 at 4:39 AM | marketbeat.comCoho Partners Ltd. Has $47.04 Million Stock Position in Johnson & Johnson $JNJOctober 19 at 4:39 AM | marketbeat.comNordea Investment Management AB Sells 180,139 Shares of Johnson & Johnson $JNJOctober 19 at 4:38 AM | marketbeat.comPraxis Investment Management Inc. Has $7.59 Million Holdings in Johnson & Johnson $JNJOctober 19 at 4:31 AM | marketbeat.comS Bank Fund Management Ltd Has $6.16 Million Position in Johnson & Johnson $JNJOctober 19 at 4:31 AM | marketbeat.comQ4 EPS Forecast for Johnson & Johnson Lowered by AnalystOctober 19 at 2:41 AM | americanbankingnews.comJohnson & Johnson's M&A Strategy Is the Real Story for Investors...October 18 at 12:04 PM | marketbeat.comAware Super Pty Ltd as trustee of Aware Super Has $42.82 Million Stock Holdings in Johnson & Johnson $JNJOctober 18 at 4:55 AM | marketbeat.comWealthPLAN Partners LLC Reduces Stock Position in Johnson & Johnson $JNJOctober 18 at 4:55 AM | marketbeat.com8,014 Shares in Johnson & Johnson $JNJ Purchased by Turtle Creek Wealth Advisors LLCOctober 18 at 4:55 AM | marketbeat.comJohnson & Johnson $JNJ Shares Acquired by WealthPlan Investment Management LLCOctober 18 at 4:55 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma GiantsBy Gabriel Osorio-Mazilli | October 6, 2025Why AbbVie and Johnson & Johnson Could Outperform PfizerBy Chris Markoch | October 8, 2025Johnson & Johnson Stock Can Keep Rising as Strategy Pays OffBy Thomas Hughes | October 15, 2025Johnson & Johnson's M&A Strategy Is the Real Story for InvestorsBy Jeffrey Neal Johnson | October 18, 2025JNJ Company DescriptionsJohnson & Johnson NYSE:JNJ$193.26 +1.15 (+0.60%) Closing price 10/17/2025 03:59 PM EasternExtended Trading$192.96 -0.30 (-0.16%) As of 10/17/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock Institutions Are Fueling CrowdStrike’s Next Leg Higher This AI Chip Giant Could Be the Market’s Next Big Winner JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall? Microsoft & NVIDIA Unveil GB300 Supercomputer as AI Race Heats Up This Less-Hyped Tech Stock Could Be the Key to the Next AI Wave Archer Buys Rival's Patent Treasure Trove in Strategic Move Prologis Stock Surges: Why the Rally May Continue Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
